130 related articles for article (PubMed ID: 8142381)
1. DNA distortion in bis-intercalated complexes.
Peek ME; Lipscomb LA; Bertrand JA; Gao Q; Roques BP; Garbay-Jaureguiberry C; Williams LD
Biochemistry; 1994 Apr; 33(13):3794-800. PubMed ID: 8142381
[TBL] [Abstract][Full Text] [Related]
2. Molecular dynamics simulations of the bis-intercalated complexes of ditercalinium and Flexi-Di with the hexanucleotide d(GCGCGC)2: theoretical analysis of the interaction and rationale for the sequence binding specificity.
de Pascual-Teresa B; Gallego J; Ortiz AR; Gago F
J Med Chem; 1996 Nov; 39(24):4810-24. PubMed ID: 8941395
[TBL] [Abstract][Full Text] [Related]
3. DNA-ditercalinium interactions: implications for recognition of damaged DNA.
Williams LD; Gao Q
Biochemistry; 1992 May; 31(17):4315-24. PubMed ID: 1567878
[TBL] [Abstract][Full Text] [Related]
4. Drug-induced DNA repair: X-ray structure of a DNA-ditercalinium complex.
Gao Q; Williams LD; Egli M; Rabinovich D; Chen SL; Quigley GJ; Rich A
Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2422-6. PubMed ID: 2006181
[TBL] [Abstract][Full Text] [Related]
5. Effects of cationic charge on three-dimensional structures of intercalative complexes: structure of a bis-intercalated DNA complex solved by MAD phasing.
Shui X; Peek ME; Lipscomb LA; Wilkinson AP; Williams LD; Gao M; Ogata C; Roques BP; Garbay-Jaureguiberry C; Wilkinson AP; Williams LD
Curr Med Chem; 2000 Jan; 7(1):59-71. PubMed ID: 10637357
[TBL] [Abstract][Full Text] [Related]
6. Recognition by the DNA repair system of DNA structural alterations induced by reversible drug-DNA interactions.
Lambert B; Segal-Bendirdjian E; Esnault C; Le Pecq JB; Roques BP; Jones B; Yeung AT
Anticancer Drug Des; 1990 Feb; 5(1):43-53. PubMed ID: 2180423
[TBL] [Abstract][Full Text] [Related]
7. Asymmetry and dynamics in bis-intercalated DNA.
Peek ME; Lipscomb LA; Haseltine J; Gao Q; Roques BP; Garbay-Jaureguiberry C; Williams LD
Bioorg Med Chem; 1995 Jun; 3(6):693-9. PubMed ID: 7582947
[TBL] [Abstract][Full Text] [Related]
8. DNA sequence recognition by the antitumor drug ditercalinium.
Crow SD; Bailly C; Garbay-Jaureguiberry C; Roques B; Shaw BR; Waring MJ
Biochemistry; 2002 Jul; 41(27):8672-82. PubMed ID: 12093285
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the bis-intercalating complexes formed between either ditercalinium or a flexible analogue and d(CpGpCpG)2 or d(TpTpCpGpCpGpApA)2 minihelices: 1H- and 31P-NMR analyses.
Pothier J; Delepierre M; Barsi MC; Garbay-Jaureguiberry C; Igolen J; Le Bret M; Roques BP
Biopolymers; 1991 Oct; 31(11):1309-23. PubMed ID: 1777582
[TBL] [Abstract][Full Text] [Related]
10. Geometry of the antitumor drug ditercalinium bisintercalated into d(CpGpCpG)2 by 1H NMR.
Delbarre A; Delepierre M; Garbay C; Igolen J; Le Pecq JB; Roques BP
Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2155-9. PubMed ID: 3470783
[TBL] [Abstract][Full Text] [Related]
11. Relationship between the size and position of substituents on 7H-pyrido[4,3-c]carbazole monomers and dimers and their DNA binding and anti-tumor properties.
Léon P; Garbay-Jaureguiberry C; Le Pecq JB; Roques BP
Anticancer Drug Des; 1988 Jun; 3(1):1-13. PubMed ID: 3382504
[TBL] [Abstract][Full Text] [Related]
12. Induction of DNA bending by bifunctional intercalating agents of the 7H-pyridocarbazole family.
Maroun RC; Roques BP
Biophys Chem; 1991 Jan; 39(1):45-56. PubMed ID: 2012833
[TBL] [Abstract][Full Text] [Related]
13. 1H- and 31P-NMR studies of ditercalinium binding to a d(GCGC)2 and d(CCTATAGG)2 minihelices: a sequence specificity study.
Delepierre M; Milhe C; Namane A; Dinh TH; Roques BP
Biopolymers; 1991 Feb; 31(3):331-53. PubMed ID: 1868161
[TBL] [Abstract][Full Text] [Related]
14. Changing DNA grooves--a 1,4,5,8-naphthalene tetracarboxylic diimide bis-intercalator with the linker (beta-Ala)(3)-Lys in the minor groove.
Guelev V; Sorey S; Hoffman DW; Iverson BL
J Am Chem Soc; 2002 Mar; 124(12):2864-5. PubMed ID: 11902864
[TBL] [Abstract][Full Text] [Related]
15. Theoretical design, chemical synthesis and footprinting analysis of a novel peptide derivative of the intercalator 7-H pyridocarbazole targeted towards the major groove of DNA.
Gresh N; René B; Hui XW; Barsi MC; Roques BP; Garbay C
J Biomol Struct Dyn; 1994 Aug; 12(1):091-110. PubMed ID: 7848561
[TBL] [Abstract][Full Text] [Related]
16. Intercalative binding of ditercalinium to d(CpGpCpG)2: a theoretical study.
Maroun R; Delepierre M; Roques BP
J Biomol Struct Dyn; 1989 Dec; 7(3):607-21. PubMed ID: 2627301
[TBL] [Abstract][Full Text] [Related]
17. Solution structure of a DNA complex with the fluorescent bis-intercalator TOTO modified on the benzothiazole ring.
Petersen M; Jacobsen JP
Bioconjug Chem; 1998; 9(3):331-40. PubMed ID: 9576807
[TBL] [Abstract][Full Text] [Related]
18. X-ray crystallographic study of DNA duplex cross-linking: simultaneous binding to two d(CGTACG)2 molecules by a bis(9-aminoacridine-4-carboxamide) derivative.
Hopcroft NH; Brogden AL; Searcey M; Cardin CJ
Nucleic Acids Res; 2006; 34(22):6663-72. PubMed ID: 17145714
[TBL] [Abstract][Full Text] [Related]
19. Effects of the bifunctional antitumor intercalator ditercalinium on DNA in mouse leukemia L1210 cells and DNA topoisomerase II.
Markovits J; Pommier Y; Mattern MR; Esnault C; Roques BP; Le Pecq JB; Kohn KW
Cancer Res; 1986 Nov; 46(11):5821-6. PubMed ID: 3019538
[TBL] [Abstract][Full Text] [Related]
20. The noncovalent complex between DNA and the bifunctional intercalator ditercalinium is a substrate for the UvrABC endonuclease of Escherichia coli.
Lambert B; Jones BK; Roques BP; Le Pecq JB; Yeung AT
Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6557-61. PubMed ID: 2671994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
